Control of viruses in humans is dependent on B cells that produce antibodies to recognise and neutralise virus particles, and T cells that recognise and remove virally infected cells. Currently, we do not know how long immune cells live for in individuals who have recovered from COVID-19. This must be determined in order to assess the risk of reinfection and identify which part of the population may benefit from vaccine boosters if a COVID-19 vaccine becomes available.
|Effective start/end date
|1/11/20 → 1/11/22
- Department of Health and Aged Care (Australia): A$998,876.00